NO20005079L - Method for sterilizing native collagen in liquid medium, resulting native-collagen mixtures containing the same and uses - Google Patents

Method for sterilizing native collagen in liquid medium, resulting native-collagen mixtures containing the same and uses

Info

Publication number
NO20005079L
NO20005079L NO20005079A NO20005079A NO20005079L NO 20005079 L NO20005079 L NO 20005079L NO 20005079 A NO20005079 A NO 20005079A NO 20005079 A NO20005079 A NO 20005079A NO 20005079 L NO20005079 L NO 20005079L
Authority
NO
Norway
Prior art keywords
collagen
native
liquid medium
sterilizing
same
Prior art date
Application number
NO20005079A
Other languages
Norwegian (no)
Other versions
NO20005079D0 (en
Inventor
Hamza Mansour
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20005079D0 publication Critical patent/NO20005079D0/en
Publication of NO20005079L publication Critical patent/NO20005079L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022Filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18Liquid substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/044Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention concerns a method for preparing native collagen, comprising pretreatment of the collagen in a mixer with double transverse cutters equipped with a system controlling agitating and shearing velocity and a thermostat, and a subsequent step of sterilising the collagen in liquid medium. The invention also concerns a sterile collagen, in particular a collagen mostly of type I, in native state and in particular pharmaceutical and/or parapharmaceutical and /or medico-surgical and/or ophthalmologic an/or cosmetic compositions and applications thereof.
NO20005079A 1998-04-10 2000-10-09 Method for sterilizing native collagen in liquid medium, resulting native-collagen mixtures containing the same and uses NO20005079L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804531A FR2777284B1 (en) 1998-04-10 1998-04-10 PROCESS FOR THE STERILIZATION OF A NATIVE COLLAGEN IN A LIQUID MEDIUM, A STERILE NATIVE COLLAGEN OBTAINED, COMPOSITIONS CONTAINING THE SAME AND APPLICATIONS
PCT/FR1999/000814 WO1999052946A1 (en) 1998-04-10 1999-04-09 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses

Publications (2)

Publication Number Publication Date
NO20005079D0 NO20005079D0 (en) 2000-10-09
NO20005079L true NO20005079L (en) 2000-12-08

Family

ID=9525129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005079A NO20005079L (en) 1998-04-10 2000-10-09 Method for sterilizing native collagen in liquid medium, resulting native-collagen mixtures containing the same and uses

Country Status (20)

Country Link
EP (1) EP1068240B1 (en)
JP (1) JP2002511489A (en)
KR (1) KR20010042539A (en)
CN (1) CN1304416A (en)
AT (1) ATE229982T1 (en)
AU (1) AU3151499A (en)
BR (1) BR9909566A (en)
CA (1) CA2327882A1 (en)
DE (1) DE69904578T2 (en)
EE (1) EE200000592A (en)
FR (1) FR2777284B1 (en)
HU (1) HUP0102575A2 (en)
ID (1) ID26038A (en)
IL (1) IL138562A0 (en)
NO (1) NO20005079L (en)
PL (1) PL343523A1 (en)
RU (1) RU2188206C2 (en)
WO (1) WO1999052946A1 (en)
YU (1) YU61100A (en)
ZA (1) ZA200005497B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
AT411326B (en) * 2000-06-20 2003-12-29 Biering Wolfgang HEMOSTATIC COLLAGEN PELLETS
RU2220724C1 (en) * 2002-11-20 2004-01-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Antibacterial and wound-healing agent "ultrakol"
CA2554994C (en) * 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
JP4705359B2 (en) * 2004-10-20 2011-06-22 新田ゼラチン株式会社 Cosmetic composition comprising avian collagen
DE102005017845A1 (en) 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptic collagen preparations, their use and methods of preparation
CN101332316B (en) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 Biotype nose bridge implantation body
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
JP5632162B2 (en) * 2007-06-01 2014-11-26 協和発酵バイオ株式会社 Oral composition
RU2433828C1 (en) * 2010-10-14 2011-11-20 Закрытое акционерное общество "БИОМИР сервис" Injection heterogenic biopolymer hydrogel for substitutional and regenerative surgery and method of its obtaining
TWI552774B (en) * 2011-05-24 2016-10-11 武田公司 Rolled collagen carrier
JP6242874B2 (en) 2012-05-24 2017-12-06 タケダ エイエスTakeda AS package
BR112014028594B1 (en) 2012-05-24 2021-11-30 Takeda As APPARATUS FOR PROVIDING A ROLLED COLLAGEN LOADER AND PROCESS TO ROLLS A COLLAGEN LOADER
CN102846536B (en) * 2012-09-26 2014-03-26 关节动力安达(天津)生物科技有限公司 Essence containing I type collagen
RU2597085C2 (en) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Implanted matrix material for regenerative medicine and method of its production (versions)
WO2019208831A1 (en) * 2018-04-27 2019-10-31 凸版印刷株式会社 Extracellular-matrix-containing composition, temporary scaffold for three-dimensional tissue formation, three-dimensional tissue formation agent, and method for recovering cells from three-dimensional tissue
RU2715715C1 (en) * 2019-03-06 2020-03-03 Общество с ограниченной ответственностью фирмы "Имтек" Sterile transparent concentrated solution of biocompatible collagen, method for production and use thereof
CN110354246A (en) * 2019-07-22 2019-10-22 中肽生物科技(大连)有限公司 A kind of preparation method of the eye-candy liquid of nanoscale small molecule complex peptides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2462222A1 (en) * 1974-02-02 1976-05-06 Trommsdorff Fa H Soluble human collagen free of non-helical peptides - prepd by treating purified collagen with ficin or pepsin, used to accelerate wound or burn healing etc.
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
DE3522626A1 (en) * 1985-06-25 1987-01-08 Merz & Co Gmbh & Co SOLUBLE COLLAGEN SPONGE
FR2586703B1 (en) * 1985-09-02 1989-12-01 Merieux Inst PROCESS FOR EXTRACTING PLACENTAL COLLAGENS, COLLAGENS OBTAINED IN PARTICULAR IN THE FORM OF GELS OR SOLUTIONS AND THEIR APPLICATIONS
IT1181737B (en) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Spongy matrix of natural animal collagen
GB8812992D0 (en) * 1988-06-01 1988-07-06 Natural Resources Mfg Ltd Improvements in/relating to protein products
RU2076718C1 (en) * 1993-04-09 1997-04-10 Курский Государственный Медицинский Институт Method of collagen preparing
FR2715309B1 (en) * 1994-01-24 1996-08-02 Imedex Adhesive composition, for surgical use, based on collagen modified by oxidative cutting and not crosslinked.
CA2146090C (en) * 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
RU2116801C1 (en) * 1995-06-15 1998-08-10 Институт элементоорганических соединений РАН Method of the porous collagen-containing material preparing
US5670369A (en) * 1996-06-25 1997-09-23 Ranpak Corporation Method for the production of soluble collagen

Also Published As

Publication number Publication date
AU3151499A (en) 1999-11-01
ATE229982T1 (en) 2003-01-15
CN1304416A (en) 2001-07-18
YU61100A (en) 2003-10-31
PL343523A1 (en) 2001-08-27
ID26038A (en) 2000-11-16
EP1068240A1 (en) 2001-01-17
CA2327882A1 (en) 1999-10-21
KR20010042539A (en) 2001-05-25
WO1999052946A1 (en) 1999-10-21
ZA200005497B (en) 2001-04-24
BR9909566A (en) 2000-12-26
EP1068240B1 (en) 2002-12-18
DE69904578T2 (en) 2003-11-20
FR2777284B1 (en) 2000-05-26
HUP0102575A2 (en) 2001-11-28
DE69904578D1 (en) 2003-01-30
JP2002511489A (en) 2002-04-16
EE200000592A (en) 2002-04-15
NO20005079D0 (en) 2000-10-09
IL138562A0 (en) 2001-10-31
RU2188206C2 (en) 2002-08-27
FR2777284A1 (en) 1999-10-15

Similar Documents

Publication Publication Date Title
NO20005079L (en) Method for sterilizing native collagen in liquid medium, resulting native-collagen mixtures containing the same and uses
IS6817A (en) Sterilization of drugs
DE69321538D1 (en) Aqueous dispersions of zein and controlled release coatings
CA2247860A1 (en) Method for treating liquid materials
DE69432832D1 (en) DEVICE AND METHOD FOR PHOTOACTIVATION
ES2032121T3 (en) GELIFIED EMULSION PARTICLES AND COMPOSITIONS CONTAINING THEM.
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR9707888A (en) Preservation and / or freezing medium for biological material, composition and storage process for biological material
DK0691858T3 (en) Two-component fibrin glue
DE602004016342D1 (en) sterilization system
ES2058117T3 (en) LIQUID STERILIZING COMPOSITION.
ES2114322T3 (en) DIALYSIS FLUID CONTAINING PEPTIDES OBTAINED FROM CASEINE AS OSMOTIC AGENTS, AND BICARBONATE IONS AS BUFFERING AGENTS.
ATE305295T1 (en) DEVICE FOR RELEASING SUBSTANCES
ES2073700T3 (en) COMPOSITION CONTAINING A POLYSACCHARIDE OBTAINED BY MICROBIAL FERMENTATION.
NO995838L (en) New heteroethynylene compounds and pharmaceutical and cosmetic preparations containing the same
ATE209647T1 (en) PYRIDINIUM SALTS AND THEIR USE FOR FIGHTING HELICOBACTER BACTERIA
MY124594A (en) Method of manufacturing an aseptic coagulated food product
BR0014058A (en) Solid product, composition, aqueous solution of 4,4-dimethyl-5α-cholesta-8,14,24-triene-3 (beta) -ol, and device having a concavity
ATE225653T1 (en) NEOMYCIN/DISACCHARIDE AQUEOUS SOLUTION FOR THE TREATMENT OF ENTEROCLYSIS IN HEPATIC ENCEPHALOPATHY
Yamamoto et al. Inhibitory Effect of Lead on the Release of Tissue Plasminogen Activator from Human Vascular Endothelial Cells in Culture (Proceedings of the 18th Symposium on Toxicology, and Environmental Health)
KR970019821A (en) Manufacturing method of toothpaste containing rosin
DE3761283D1 (en) COMPOSITIONS FOR DISINFECTION AND STERILIZATION.
KR970042591A (en) Liquid Heat Treatment Method of Protein Solution Using Trehalose as Stabilizer
Tsuji et al. An Application of Fuzzy System to Orthodontic Diagnosis in Orthosurgical Case
Kaji et al. Remodeling of Vascular Endothelial Glycocalyx by Basic Fibroblast Growth Factor (Proceedings of the 23rd Symposium on Toxicology and Environmental Health)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application